AbbVie ABBV

NYS: ABBV | ISIN: US00287Y1091   25/09/2026
264,34 USD (-0,29%)
(-0,29%)   25/09/2026
Grafiek AbbVie Inc. Grafiek AbbVie Inc.

AbbVie Inc. in het nieuws

22 september 2026 · Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach · Persbericht

22 september 2026 · AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis · Persbericht

21 september 2026 · AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery · Persbericht

18 september 2026 · AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026 · Persbericht

17 september 2026 · AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting · Persbericht

17 september 2026 · Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications · Persbericht

15 september 2026 · AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign · Persbericht

15 september 2026 · Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit · Persbericht

10 september 2026 · AbbVie Declares Quarterly Dividend · Persbericht

10 september 2026 · AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine · Persbericht

Profiel AbbVie Inc.

Fabricage van farmaceutische preparaten
Farmaceutica
Gezondheidstechnologie
Productie

Website: www.abbvie.com

Hoofdzetel: North Chicago, Illinois vlag Verenigde Staten

Mijn selecties